Depression
Conditions
Keywords
depression, primary care, pharmacotherapy
Brief summary
A randomized clinical trial was carried out at primary care level in Santiago, Chile to compare a pharmacological intervention for depressed mothers controlled by phone from a central level (TM) and the usual treatment (TH) and its impact on children's mental health. Hypothesis: pharmacological intervention for depression controlled by phone from a central level will be more effective than usual care in depressed mothers.
Detailed description
Aim:to compare a pharmacological intervention for depressed mothers controlled by phone from a central level (TM) and the usual treatment (TH) and its impact on children's mental health. Material and methods: A RCT wasw carried out at primary care clinics in Santiago.Sample:three hundred and forty five depressed women . One children of each mother was randomly selected. Women are randomly assigned to receive the usual therapy or a pharmacological intervention with periodical telephone contacts with medical collaboration personnel, to reinforce compliance with treatment and educate about the disease, for 6 months. Women were blindly evaluated at 3, 6 and 12 months with the Hamilton depression rating score (HDRS) and the SF-36 to assess depressive symptoms and quality of life, respectively; the Dyadic Adjustment Scale to assess marital adjustment. Child psychopathology was assessed with the Child Behavior Checklist (CBCL), the Brief Psychiatric Rating Scale for Children (BPRS-C), Screen for Child Anxiety Related Emotional Disorders(SCARED)and the Children's Depression Inventory.
Interventions
Fluoxetine oral,20-60 mg/day for 6 months with telephone monitorization
Sponsors
Study design
Eligibility
Inclusion criteria
* depressed mothers with al least one child aged 6-16
Exclusion criteria
* currently treatment for depression,psychosis,bipolar depression,alcohol or drug abuse, gravidity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| depressive symptoms measured with the HDRS | at 3,6 and 12 months after randomization |
Secondary
| Measure | Time frame |
|---|---|
| quality of life measured with the SF-36 | at 3,6 and 12 months after randomization |
Countries
Chile